Showing results (431-440 of 1,988) with videos related to

Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|August 10, 2016
Morbidity and mortality after surgery for lower urinary tract symptoms: a study of 95 577 cases from a nationwide German health insurance databaseC Gilfrich, H Leicht, C Fahlenbrach, et al.
Prostate Cancer and Prostatic Diseases|August 10, 2016
Tumor features and survival after radical prostatectomy among antidiabetic drug usersR M Joentausta, P M Kujala, T Visakorpi, et al.
Prostate Cancer and Prostatic Diseases|July 15, 2015
Intraprostatic ethanol diffusion: comparison of two injection methods using ex vivo human prostatesB J King, T K Mann-Gow, M Kida, et al.
Prostate Cancer and Prostatic Diseases|July 15, 2015
Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancerA J Zurita, L L Pisters, X Wang, et al.
Prostate Cancer and Prostatic Diseases|June 24, 2015
Primary radiotherapy vs conservative management for localized prostate cancer--a population-based studyG L Lu-Yao, S Kim, D F Moore, et al.
Prostate Cancer and Prostatic Diseases|May 2, 2021
Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour controlMarieke J van Son, Max Peters, Deepika Reddy, et al.
Prostate Cancer and Prostatic Diseases|June 10, 2020
Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized diseaseReith R Sarkar, Sunil H Patel, J Kellogg Parsons, et al.
Prostate Cancer and Prostatic Diseases|June 10, 2020
Evidence-based analysis of online consumer information about prostate artery embolization for benign prostatic hyperplasiaMitchell M Huang, Jared S Winoker, Brian R Matlaga, et al.
Prostate Cancer and Prostatic Diseases|August 22, 2021
Efficacy of enzalutamide in subgroups of men with metastatic hormone-sensitive prostate cancer based on prior therapy, disease volume, and riskArun A Azad, Andrew J Armstrong, Antonio Alcaraz, et al.
Prostate Cancer and Prostatic Diseases|March 25, 2023
Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern eraTing Martin Ma, Felix Y Feng, Seth A Rosenthal, et al.
Pageof 199